Rep. Israel: Generic Drug Supply Needs Better OversightU.S. Rep. Steve Israel (D-N.Y.) of Long Island thinks the recent Ranbaxy case shows the U.S. Food and Drug Administration may be asleep at the wheel.

More From CBS New York

Get Our Morning Briefs
Bloomberg WCBS Tri-State Business Index

Listen Live